Strong Financial Performance Jubilant Pharmova reported a 14 percent year-on-year revenue increase to Rs 8,280 crore for the financial year 2025-26, fueled by significant expansion in its CDMO Sterile Injectables, Allergy Immunotherapy, and Generics divisions. The company announced an 8 percent rise in EBITDA to Rs 1,326 crore and a 7 percent increase in normalized…
Private equity giant CVC Capital Partners and investment holding company Groupe Bruxelles Lambert (GBL) announced a joint bid this week to take the Italian pharmaceutical firm Recordati private, valuing the company at approximately $12.47 billion. The move, which aims to delist the Milan-based drugmaker from the Borsa Italiana, represents one of the most significant healthcare…
Eli Lilly and Company announced on May 6 a massive $4.5 billion investment to expand its manufacturing footprint in Lebanon, Indiana. The pharmaceutical giant is scaling up its production capabilities to meet surging global demand for its existing medications and to support a rapidly evolving pipeline of new drug therapies. Building the Future of Advanced…
